16735679	Sodium	Kobayashi T	Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.	Circulation	2006	77
20723802	Sodium	Behfar A	Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction.	Journal of the American College of Cardiology	2010	69
24158986	Sodium	Scialla JJ	Fibroblast growth factor-23 and cardiovascular events in CKD.	Journal of the American Society of Nephrology 	2014	87
21742056	Estradiol	Meyer MR	The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.	Vascular pharmacology	2011	38
25069991	Estradiol	Harman SM	Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.	Annals of internal medicine	2014	47
27028912	Estradiol	Hodis HN	Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.	The New England journal of medicine	2016	34
21281456	Estrogens	Meyer MR	Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.	Acta physiologica	2011	56
23753408	Aldosterone	Savard S	Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.	Hypertension	2013	38
26678809	Aldosterone	Jia G	Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.	Nature reviews. Endocrinology	2016	44
10845877	Insulin	Hotta K	Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.	Arteriosclerosis, thrombosis, and vascular biology	2000	457
12771873	Insulin	Furnary AP	Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.	The Journal of thoracic and cardiovascular surgery	2003	129
17276175	Insulin	Han SH	Adiponectin and cardiovascular disease: response to therapeutic interventions.	Journal of the American College of Cardiology	2007	60
21873549	Insulin	Strawbridge RJ	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Diabetes	2011	106
22055501	Insulin	Bornfeldt KE	Insulin resistance, hyperglycemia, and atherosclerosis.	Cell metabolism	2011	117
26063450	Insulin	Ferrannini E	Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.	European heart journal	2015	33
27565734	Insulin	Sawada T	Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.	Cardiovascular diabetology	2016	12
23389416	Phosphates	Scialla JJ	Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.	Kidney international	2013	67
12512688	Nitroglycerin	Ignarro LJ	Nitric oxide as a unique signaling molecule in the vascular system: a historical overview.	Journal of physiology and pharmacology 	2002	149
15862416	Nitroglycerin	Heiss C	Impaired progenitor cell activity in age-related endothelial dysfunction.	Journal of the American College of Cardiology	2005	112
10880413	Glucose	Festa A	Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).	Circulation	2000	338
11502817	Glucose	Yang WS	Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.	The Journal of clinical endocrinology and metabolism	2001	131
16412224	Glucose	Baker AR	Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.	Cardiovascular diabetology	2006	134
16618833	Glucose	Kim JA	Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.	Circulation	2006	292
18230953	Glucose	Aronson D	Hyperglycemia and the pathobiology of diabetic complications.	Advances in cardiology	2008	71
18235500	Glucose	Miller EJ	Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart.	Nature	2008	145
19805772	Glucose	Helfand M	Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force.	Annals of internal medicine	2009	63
20829514	Glucose	Lima FO	The pattern of leptomeningeal collaterals on CT angiography is a strong predictor of long-term functional outcome in stroke patients with large vessel intracranial occlusion.	Stroke	2010	49
22876189	Glucose	Voight BF	The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits.	PLoS genetics	2012	218
23134073	Glucose	Woo YC	Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.	Clinical endocrinology	2013	50
23386232	Glucose	Matsubara J	Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.	Circulation journal 	2013	35
23932046	Glucose	Palomer X	An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.	International journal of cardiology	2013	40
24014835	Glucose	Jansen F	Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles.	Circulation	2013	84
24169007	Glucose	Shechter M	Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease.	The American journal of cardiology	2014	22
24194499	Glucose	Kanaya AM	Mediators of Atherosclerosis in South Asians Living in America (MASALA) study: objectives, methods, and cohort description.	Clinical cardiology	2013	37
24951766	Glucose	Ryan JJ	The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.	Circulation research	2014	46
26386349	Glucose	Munasinghe PE	Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway.	International journal of cardiology	2016	13
26926996	Glucose	Shirai T	The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease.	The Journal of experimental medicine	2016	40
28065883	Glucose	Rawal S	Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy.	Cardiovascular research	2017	10
12810615	Acetylcholine	Hambrecht R	Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase.	Circulation	2003	142
22240132	Acetylcholine	Matsubara J	A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.	Journal of the American College of Cardiology	2012	68
25389999	Acetylcholine	López-Jaramillo P	The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.	Hormone molecular biology and clinical investigation	2014	36
24076493	Adenosine Diphosphate	Tantry US	Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.	Journal of the American College of Cardiology	2013	72
10431238	Adenosine Triphosphate	Rust S	Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.	Nature genetics	1999	237
26323267	Adenosine Triphosphate	Rosenson RS	Dysfunctional HDL and atherosclerotic cardiovascular disease.	Nature reviews. Cardiology	2016	57
28437620	Adenosine Triphosphate	Jellinger PS	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.	Endocrine practice 	2017	24
12192226	Aspirin	Ford ES	Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults.	Epidemiology	2002	89
15677512	Aspirin	Schulze MB	Adiponectin and future coronary heart disease events among men with type 2 diabetes.	Diabetes	2005	69
18832751	Aspirin	Shaw JA	Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.	Circulation research	2008	68
22405251	Aspirin	Kobayashi T	Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.	Lancet	2012	44
26232640	Aspirin	Mackenzie AE	The emerging pharmacology and function of GPR35 in the nervous system.	Neuropharmacology	2017	6
12081584	Parathyroid Hormone	Chertow GM	Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.	Kidney international	2002	190
11566918	Oxygen	London GM	Arterial wave reflections and survival in end-stage renal failure.	Hypertension	2001	116
16254208	Oxygen	Hemdahl AL	Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction.	Arteriosclerosis, thrombosis, and vascular biology	2006	70
19281826	Oxygen	Roberts CK	Oxidative stress and metabolic syndrome.	Life sciences	2009	117
23856679	Oxygen	Taimeh Z	Vascular endothelial growth factor in heart failure.	Nature reviews. Cardiology	2013	31
16000355	Phospholipids	Tsimikas S	Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.	The New England journal of medicine	2005	117
17541022	Phospholipids	Kiechl S	Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.	Arteriosclerosis, thrombosis, and vascular biology	2007	67
21226665	Phospholipids	Tsimikas S	Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease.	Current pharmaceutical design	2011	43
3277611	Cholesterol	Davignon J	Apolipoprotein E polymorphism and atherosclerosis.	Arteriosclerosis	1988	209
3283935	Cholesterol	Mahley RW	Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.	Science	1988	644
9920074	Cholesterol	Banerji MA	Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.	The Journal of clinical endocrinology and metabolism	1999	105
11138003	Cholesterol	Lee MH	Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption.	Nature genetics	2001	100
11440984	Cholesterol	Vasa M	Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.	Circulation research	2001	440
11882522	Cholesterol	Eichner JE	Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.	American journal of epidemiology	2002	162
12020339	Cholesterol	Beckman JA	Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.	JAMA	2002	376
12611609	Cholesterol	Díez JJ	The role of the novel adipocyte-derived hormone adiponectin in human disease.	European journal of endocrinology	2003	167
12716665	Cholesterol	Mensink RP	Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials.	The American journal of clinical nutrition	2003	304
14668457	Cholesterol	Kolodgie FD	Intraplaque hemorrhage and progression of coronary atheroma.	The New England journal of medicine	2003	196
15023877	Cholesterol	Hsue PY	Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.	Circulation	2004	162
15142859	Cholesterol	Burke AP	Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study.	Arteriosclerosis, thrombosis, and vascular biology	2004	98
15625072	Cholesterol	Muntner P	Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.	Journal of the American Society of Nephrology 	2005	94
15635110	Cholesterol	Nissen SE	Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.	The New England journal of medicine	2005	150
15660501	Cholesterol	Moller DE	Metabolic syndrome: a clinical and molecular perspective.	Annual review of medicine	2005	116
15677572	Cholesterol	Arking DE	Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity.	Circulation research	2005	71
16476102	Cholesterol	Barter PJ	Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.	Journal of internal medicine	2006	71
16567568	Cholesterol	Ix JH	Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.	Circulation	2006	64
16786033	Cholesterol	Martins IJ	Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease.	Molecular psychiatry	2006	82
16801565	Cholesterol	Knopp RH	Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).	Diabetes care	2006	74
17076584	Cholesterol	Mujawar Z	Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.	PLoS biology	2006	120
17276177	Cholesterol	El Harchaoui K	Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.	Journal of the American College of Cardiology	2007	70
17332893	Cholesterol	Vaisar T	Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.	The Journal of clinical investigation	2007	255
17387133	Cholesterol	Tardif JC	Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.	JAMA	2007	145
17485598	Cholesterol	Roman MJ	Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study.	Hypertension	2007	154
17616301	Cholesterol	Meuwese MC	Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.	Journal of the American College of Cardiology	2007	82
17906084	Cholesterol	Young RP	Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes.	The European respiratory journal	2007	63
18048406	Cholesterol	Broadbent HM	Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.	Human molecular genetics	2008	152
18261682	Cholesterol	van der Steeg WA	High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.	Journal of the American College of Cardiology	2008	64
18462017	Cholesterol	Schadt EE	Mapping the genetic architecture of gene expression in human liver.	PLoS biology	2008	502
19074352	Cholesterol	Pollin TI	A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.	Science	2008	175
19281927	Cholesterol	Patel S	Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.	Journal of the American College of Cardiology	2009	59
19291789	Cholesterol	Gastaldelli A	Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.	Hepatology	2009	66
19497986	Cholesterol	Lehrke M	Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.	European journal of endocrinology	2009	57
19630828	Cholesterol	Ridker PM	Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).	Journal of thrombosis and haemostasis 	2009	75
19698799	Cholesterol	Curcio CA	Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.	Progress in retinal and eye research	2009	90
19797256	Cholesterol	Curcio CA	Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.	Journal of lipid research	2010	58
19952353	Cholesterol	Crowe SM	The macrophage: the intersection between HIV infection and atherosclerosis.	Journal of leukocyte biology	2010	47
19996940	Cholesterol	Lo J	Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.	AIDS	2010	105
20172445	Cholesterol	Stevens LA	Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).	American journal of kidney diseases 	2010	59
20686566	Cholesterol	Musunuru K	From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus.	Nature	2010	367
21349201	Cholesterol	Su G	Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.	Cardiovascular diabetology	2011	51
21792295	Cholesterol	Kones R	Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.	Drug design, development and therapy	2011	43
21840418	Cholesterol	Alwaili K	The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.	Biochimica et biophysica acta	2012	39
21856482	Cholesterol	Blaha MJ	Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study.	Lancet	2011	66
21982649	Cholesterol	Ridker PM	Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).	American heart journal	2011	187
22271511	Cholesterol	Kim D	Nonalcoholic fatty liver disease is associated with coronary artery calcification.	Hepatology	2012	60
22453571	Cholesterol	Boekholdt SM	Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.	JAMA	2012	105
22587332	Cholesterol	Gao W	Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease.	Lipids in health and disease	2012	48
22893714	Cholesterol	Benn M	Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.	The Journal of clinical endocrinology and metabolism	2012	63
22998429	Cholesterol	Kronenberg F	Lipoprotein(a): resurrected by genetics.	Journal of internal medicine	2013	61
23083789	Cholesterol	Ference BA	Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis.	Journal of the American College of Cardiology	2012	75
23471228	Cholesterol	Shimabukuro M	Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2013	25
23520163	Cholesterol	Li XM	Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.	Arteriosclerosis, thrombosis, and vascular biology	2013	69
23584084	Cholesterol	Klop B	Dyslipidemia in obesity: mechanisms and potential targets.	Nutrients	2013	99
23663738	Cholesterol	Nagareddy PR	Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.	Cell metabolism	2013	76
23817481	Cholesterol	Egan BM	Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.	Circulation	2013	28
23981342	Cholesterol	Shen Y	Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.	Cardiovascular diabetology	2013	27
24345402	Cholesterol	Mora S	Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events.	Circulation	2014	27
24378418	Cholesterol	Reed B	Associations between serum cholesterol levels and cerebral amyloidosis.	JAMA neurology	2014	37
24422572	Cholesterol	Jesus AA	IL-1 blockade in autoinflammatory syndromes.	Annual review of medicine	2014	46
24481950	Cholesterol	Allahverdian S	Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis.	Circulation	2014	67
24534455	Cholesterol	Martinet W	mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques.	Atherosclerosis	2014	31
24647144	Cholesterol	Shao B	Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.	Circulation research	2014	45
24663222	Cholesterol	Laakso M	Insulin resistance and hyperglycaemia in cardiovascular disease development.	Nature reviews. Endocrinology	2014	44
24691204	Cholesterol	Longenecker CT	Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.	AIDS	2014	50
26153245	Cholesterol	Ding J	Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease.	Diabetes	2015	20
26227186	Cholesterol	Tsujita K	Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.	Journal of the American College of Cardiology	2015	25
26558731	Cholesterol	Nou E	Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.	AIDS	2016	13
26718096	Cholesterol	Banach M	Lipids, blood pressure and kidney update 2015.	Lipids in health and disease	2015	17
26908947	Cholesterol	Benn M	Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.	European heart journal	2016	20
26920601	Cholesterol	Sabatine MS	Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial.	American heart journal	2016	25
26933753	Cholesterol	Dewey FE	Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.	The New England journal of medicine	2016	54
27015805	Cholesterol	Pilling LC	Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participants.	Aging	2016	16
27135400	Cholesterol	Helgadottir A	Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease.	Nature genetics	2016	39
27192541	Cholesterol	Nioi P	Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.	The New England journal of medicine	2016	13
27515591	Cholesterol	Bowe B	High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.	Clinical journal of the American Society of Nephrology 	2016	15
27540175	Cholesterol	Franzén O	Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases.	Science	2016	28
27701660	Cholesterol	Lotta LA	Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.	JAMA	2016	38
28057795	Cholesterol	Oesterle A	Pleiotropic Effects of Statins on the Cardiovascular System.	Circulation research	2017	20
28288972	Cholesterol	Bacchiega BC	Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study.	Journal of the American Heart Association	2017	8
28385496	Cholesterol	Stitziel NO	ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.	Journal of the American College of Cardiology	2017	19
28538136	Cholesterol	Dewey FE	Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.	The New England journal of medicine	2017	24
10807470	Creatinine	Gottdiener JS	Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.	Journal of the American College of Cardiology	2000	208
20212276	Creatinine	Ix JH	Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study.	Circulation	2010	41
20837926	Creatinine	Rahman IA	Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?	Circulation	2010	52
21098347	Creatinine	Roussel R	Metformin use and mortality among patients with diabetes and atherothrombosis.	Archives of internal medicine	2010	58
21338849	Creatinine	Stevens LA	Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP).	American journal of kidney diseases 	2011	42
23887638	Creatinine	Chow WS	Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.	Arteriosclerosis, thrombosis, and vascular biology	2013	33
25029429	Creatinine	Langefeld CD	Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.	Kidney international	2015	35
25075773	Creatinine	Gallagher SM	Remote ischemic preconditioning has a neutral effect on the incidence of kidney injury after coronary artery bypass graft surgery.	Kidney international	2015	17
25393378	Creatinine	Naik RP	Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.	JAMA	2014	34
26180129	Creatinine	Peralta CA	APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.	Journal of the American Society of Nephrology 	2016	18
18585721	Uric Acid	Gagliardi AC	Uric acid: A marker of increased cardiovascular risk.	Atherosclerosis	2009	65
11588264	Triglycerides	Pennacchio LA	An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.	Science	2001	200
18193043	Triglycerides	Willer CJ	Newly identified loci that influence lipid concentrations and risk of coronary artery disease.	Nature genetics	2008	617
18193044	Triglycerides	Kathiresan S	Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.	Nature genetics	2008	503
20864672	Triglycerides	Waterworth DM	Genetic variants influencing circulating lipid levels and risk of coronary artery disease.	Arteriosclerosis, thrombosis, and vascular biology	2010	148
22466652	Triglycerides	Ai D	Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice.	The Journal of clinical investigation	2012	35
22654671	Triglycerides	Ma L	Knowledge-driven analysis identifies a gene-gene interaction affecting high-density lipoprotein cholesterol levels in multi-ethnic populations.	PLoS genetics	2012	37
24474739	Triglycerides	Holmes MV	Mendelian randomization of blood lipids for coronary heart disease.	European heart journal	2015	72
26892959	Triglycerides	Musunuru K	Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.	Circulation research	2016	12
26934567	Triglycerides	Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators.	Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.	The New England journal of medicine	2016	70
11222466	Cholesterol Esters	Ouchi N	Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages.	Circulation	2001	189
22433576	Anticoagulants	Skanes AC	Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.	The Canadian journal of cardiology	2012	77
11237216	Fatty Acids	Kliewer SA	Peroxisome proliferator-activated receptors: from genes to physiology.	Recent progress in hormone research	2001	90
20935172	Fatty Acids	Love-Gregory L	Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.	Human molecular genetics	2011	43
20978091	Fatty Acids	Schauer IE	Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.	Diabetes	2011	57
22607863	Fatty Acids	Shah SH	Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.	American heart journal	2012	58
23813974	Fatty Acids	Bochenek G	The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10.	Human molecular genetics	2013	40
23666091	Fatty Acids, Nonesterified	Gaggini M	Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.	Nutrients	2013	91
24529130	Fatty Acids, Nonesterified	Alexopoulos N	Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis.	Atherosclerosis	2014	37
10974057	Hydrogen Peroxide	Navab M	Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.	Journal of lipid research	2000	99
27872049	Hydrogen Peroxide	Nishijima Y	Contribution of KV1.5 Channel to Hydrogen Peroxide-Induced Human Arteriolar Dilation and Its Modulation by Coronary Artery Disease.	Circulation research	2017	8
15505111	Adrenal Cortex Hormones	Newburger JW	Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.	Circulation	2004	292
15574639	Adrenal Cortex Hormones	Newburger JW	Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.	Pediatrics	2004	203
14573732	Glutathione	Blankenberg S	Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.	The New England journal of medicine	2003	106
9509248	Folic Acid	Refsum H	Homocysteine and cardiovascular disease.	Annual review of medicine	1998	216
11929966	Folic Acid	Friso S	A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status.	Proceedings of the National Academy of Sciences of the United States of America	2002	197
15284284	Nitric Oxide	Endemann DH	Endothelial dysfunction.	Journal of the American Society of Nephrology 	2004	167
16894049	Nitric Oxide	Goldin A	Advanced glycation end products: sparking the development of diabetic vascular injury.	Circulation	2006	346
19786632	Nitric Oxide	Menghini R	MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1.	Circulation	2009	122
20678595	Nitric Oxide	Sitia S	From endothelial dysfunction to atherosclerosis.	Autoimmunity reviews	2010	56
22079549	Nitric Oxide	Toda N	Age-related changes in endothelial function and blood flow regulation.	Pharmacology & therapeutics	2012	34
23007404	Nitric Oxide	Cortese-Krott MM	Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease.	Blood	2012	35
23349247	Nitric Oxide	Riwanto M	Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.	Circulation	2013	61
25550450	Nitric Oxide	Chen Z	Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a.	Circulation	2015	33
11914250	Superoxides	Sorescu D	Superoxide production and expression of nox family proteins in human atherosclerosis.	Circulation	2002	191
16293794	Superoxides	Guzik TJ	Coronary artery superoxide production and nox isoform expression in human coronary artery disease.	Arteriosclerosis, thrombosis, and vascular biology	2006	75
19297385	Superoxides	Antoniades C	Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.	European heart journal	2009	59
22140047	Superoxides	Bubolz AH	Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca2+ entry and mitochondrial ROS signaling.	American journal of physiology. Heart and circulatory physiology	2012	41
11923039	Dobutamine	Allman KC	Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.	Journal of the American College of Cardiology	2002	105
26417060	Platelet Aggregation Inhibitors	Byrne RA	Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.	European heart journal	2015	28
14996776	Pravastatin	Nissen SE	Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.	JAMA	2004	227
12771008	Adenosine	Hachamovitch R	Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.	Circulation	2003	134
16631001	Adenosine	Klem I	Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.	Journal of the American College of Cardiology	2006	79
19808590	Adenosine	George RT	Adenosine stress 64- and 256-row detector computed tomography angiography and perfusion imaging: a pilot study evaluating the transmural extent of perfusion abnormalities to predict atherosclerosis causing myocardial ischemia.	Circulation. Cardiovascular imaging	2009	55
27595325	Adenosine	Stellos K	Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.	Nature medicine	2016	19
15820197	Reactive Oxygen Species	Brandes RP	Endothelial aging.	Cardiovascular research	2005	126
19022160	Reactive Oxygen Species	Guzik TJ	Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease.	Journal of the American College of Cardiology	2008	87
25253673	Reactive Oxygen Species	Ebert AD	Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system.	Science translational medicine	2014	29
10431237	Cholesterol, HDL	Bodzioch M	The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.	Nature genetics	1999	260
17284700	Cholesterol, HDL	Nicholls SJ	Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.	JAMA	2007	102
19153411	Cholesterol, HDL	El Harchaoui K	High-density lipoprotein particle size and concentration and coronary risk.	Annals of internal medicine	2009	67
22539783	Cholesterol, HDL	Parish S	Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.	Circulation	2012	50
19151200	Glucagon-Like Peptide 1	Noyan-Ashraf MH	GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.	Diabetes	2009	119
20075143	Glucagon-Like Peptide 1	Read PA	DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease.	Circulation. Cardiovascular imaging	2010	47
18154959	Natriuretic Peptide, Brain	Daniels LB	Natriuretic peptides.	Journal of the American College of Cardiology	2007	143
21733911	Natriuretic Peptide, Brain	Seiler S	The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.	European heart journal	2011	41
22431676	Natriuretic Peptide, Brain	Kavousi M	Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.	Annals of internal medicine	2012	68
22806632	Natriuretic Peptide, Brain	van Heerebeek L	Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.	Circulation	2012	67
24275629	Natriuretic Peptide, Brain	Matsuzawa Y	Peripheral endothelial function and cardiovascular events in high-risk patients.	Journal of the American Heart Association	2013	33
9385294	Antihypertensive Agents	-	The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.	Archives of internal medicine	1997	460
21701070	Malondialdehyde	Besler C	Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.	The Journal of clinical investigation	2011	122
13678872	Angiotensin-Converting Enzyme Inhibitors	Fox KM	Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).	Lancet	2003	199
18371492	Angiotensin-Converting Enzyme Inhibitors	Ho PM	Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease.	American heart journal	2008	105
23414791	Angiotensin-Converting Enzyme Inhibitors	Omland T	Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.	Journal of the American College of Cardiology	2013	36
18842780	Arachidonic Acid	Martinelli N	FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease.	The American journal of clinical nutrition	2008	87
23701967	Arachidonic Acid	Harris TR	Soluble epoxide hydrolase: gene structure, expression and deletion.	Gene	2013	30
26424461	Simvastatin	Lo J	Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.	The lancet. HIV	2015	44
27846344	Simvastatin	Nicholls SJ	Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.	JAMA	2016	50
20394901	Fluorodeoxyglucose F18	Rogers IS	Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina.	JACC. Cardiovascular imaging	2010	55
22820791	Fluorodeoxyglucose F18	Subramanian S	Arterial inflammation in patients with HIV.	JAMA	2012	144
24488982	Fluorodeoxyglucose F18	Kim EJ	Metabolic activity of the spleen and bone marrow in patients with acute myocardial infarction evaluated by 18f-fluorodeoxyglucose positron emission tomograpic imaging.	Circulation. Cardiovascular imaging	2014	24
24957699	Hypoglycemic Agents	Fisman EZ	Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?	Cardiovascular diabetology	2014	42
12460879	Creatine	Weinberg EO	Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.	Circulation	2002	106
14573731	Creatine	Brennan ML	Prognostic value of myeloperoxidase in patients with chest pain.	The New England journal of medicine	2003	154
11940543	sapropterin	Guzik TJ	Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.	Circulation	2002	209
21730307	sapropterin	Antoniades C	Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.	Circulation	2011	44
24180381	sapropterin	Karbach S	eNOS uncoupling in cardiovascular diseases--the role of oxidative stress and inflammation.	Current pharmaceutical design	2014	42
11489932	Hydroxymethylglutaryl-CoA Reductase Inhibitors	Dimmeler S	HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.	The Journal of clinical investigation	2001	192
16634986	Thiazolidinediones	Whitehead JP	Adiponectin--a key adipokine in the metabolic syndrome.	Diabetes, obesity & metabolism	2006	102
19567523	Thiazolidinediones	Sacks HS	Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat.	The Journal of clinical endocrinology and metabolism	2009	51
15537681	Niacin	Taylor AJ	Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.	Circulation	2004	122
440357	Thallium	Diamond GA	Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease.	The New England journal of medicine	1979	201
23128163	Cholesterol, LDL	Sullivan D	Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.	JAMA	2012	68
25487149	Cholesterol, LDL	Do R	Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.	Nature	2015	120
26578202	Cholesterol, LDL	Lipinski MJ	The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis.	European heart journal	2016	35
27050191	Cholesterol, LDL	Khera AV	Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.	Journal of the American College of Cardiology	2016	31
15531767	trandolapril	Braunwald E	Angiotensin-converting-enzyme inhibition in stable coronary artery disease.	The New England journal of medicine	2004	128
12746275	pioglitazone	Lee CH	Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.	Endocrinology	2003	161
21226578	pioglitazone	Khera AV	Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.	The New England journal of medicine	2011	458
17599422	Fenofibrate	ACCORD Study Group.	Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.	The American journal of cardiology	2007	117
7647779	5-methyltetrahydrofolate	Frosst P	A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.	Nature genetics	1995	668
12796140	clopidogrel	Gurbel PA	Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.	Circulation	2003	158
19081411	clopidogrel	Siller-Matula JM	Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel.	American heart journal	2009	49
19706858	clopidogrel	Shuldiner AR	Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.	JAMA	2009	265
19923168	clopidogrel	Gurbel PA	Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.	Circulation	2009	99
20083681	clopidogrel	Sibbing D	Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.	Circulation	2010	96
20179285	clopidogrel	Breet NJ	Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.	JAMA	2010	91
20194878	clopidogrel	Gurbel PA	Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.	Circulation	2010	50
20435227	clopidogrel	Ashley EA	Clinical assessment incorporating a personal genome.	Lancet	2010	239
20828644	clopidogrel	Bonello L	Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.	Journal of the American College of Cardiology	2010	106
21170047	clopidogrel	Bouman HJ	Paraoxonase-1 is a major determinant of clopidogrel efficacy.	Nature medicine	2011	91
21816733	clopidogrel	Bauer T	Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.	BMJ	2011	39
22520250	clopidogrel	Trenk D	A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.	Journal of the American College of Cardiology	2012	59
23111421	clopidogrel	Lewis JP	The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response.	Pharmacogenetics and genomics	2013	34
23890998	clopidogrel	Stone GW	Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.	Lancet	2013	48
19608026	pitavastatin	Hiro T	Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome study).	Journal of the American College of Cardiology	2009	48
15716560	pro-brain natriuretic peptide (1-76)	Kragelund C	N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.	The New England journal of medicine	2005	82
24733959	pro-brain natriuretic peptide (1-76)	Ji Q	Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.	Mediators of inflammation	2014	24
25599331	trimethyloxamine	Tang WH	Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.	Circulation research	2015	108
26229137	trimethyloxamine	Stubbs JR	Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.	Journal of the American Society of Nephrology 	2016	40
26694027	trimethyloxamine	Bennett BJ	Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains.	PLoS genetics	2015	17
27256833	trimethyloxamine	Senthong V	Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.	Journal of the American College of Cardiology	2016	20
9600480	3-hydroxy-3-methylglutaryl-coenzyme A	Avorn J	Persistence of use of lipid-lowering medications: a cross-national study.	JAMA	1998	113
24227810	Natriuretic Peptides	Volpe M	Natriuretic peptides in cardiovascular diseases: current use and perspectives.	European heart journal	2014	30
21908036	dalcetrapib	Fayad ZA	Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.	Lancet	2011	120
22345126	dalcetrapib	Lüscher TF	Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial.	European heart journal	2012	37
18571548	Alanine	Tremoulet AH	Resistance to intravenous immunoglobulin in children with Kawasaki disease.	The Journal of pediatrics	2008	65
14600188	ETC216	Nissen SE	Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.	JAMA	2003	298
17387129	torcetrapib	Nissen SE	Effect of torcetrapib on the progression of coronary atherosclerosis.	The New England journal of medicine	2007	160
20227758	mipomersen	Raal FJ	Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.	Lancet	2010	143
23060426	mipomersen	Stein EA	Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.	Circulation	2012	43
19007931	oligophosphoglycerol-ATP	Van Campenhout A	Osteoprotegerin, vascular calcification and atherosclerosis.	Atherosclerosis	2009	49
